ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	6/141	26/7206	8.41352211249e-06
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	5/141	19/7206	2.49093769026e-05
ko04144	Endocytosis	19/141	342/7206	3.36265548412e-05
ko00310	Lysine degradation	7/141	73/7206	0.000524847650599
ko04080	Neuroactive ligand-receptor interaction	1/141	423/7206	0.00323855915584
ko05200	Pathways in cancer	19/141	492/7206	0.00369293998619
ko04520	Adherens junction	7/141	103/7206	0.00392773273078
ko05211	Renal cell carcinoma	6/141	96/7206	0.0110759769802
ko00515	Mannose type O-glycan biosynthesis	3/141	25/7206	0.0123083207082
ko04152	AMPK signaling pathway	8/141	161/7206	0.0134382429253
ko04350	TGF-beta signaling pathway	6/141	103/7206	0.0152971808593
ko01521	EGFR tyrosine kinase inhibitor resistance	6/141	106/7206	0.0174085991632
ko05214	Glioma	5/141	79/7206	0.0189379496474
ko04012	ErbB signaling pathway	6/141	109/7206	0.0197127559651
ko05206	MicroRNAs in cancer	8/141	177/7206	0.0225033908661
ko05212	Pancreatic cancer	5/141	83/7206	0.0229422116764
ko05220	Chronic myeloid leukemia	5/141	85/7206	0.0251353182254
ko05210	Colorectal cancer	5/141	86/7206	0.0262806986343
ko05202	Transcriptional misregulation in cancer	8/141	188/7206	0.0308244778322
ko04066	HIF-1 signaling pathway	6/141	123/7206	0.0332148019928
ko05223	Non-small cell lung cancer	4/141	66/7206	0.0398141904378
ko04140	Autophagy - animal	7/141	164/7206	0.0415570124995
ko04068	FoxO signaling pathway	7/141	167/7206	0.0450968839539